The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

Amidst October's volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They ...

For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

After pledging to allow politician and vaccine skeptic Robert Francis Kennedy Jr. | Trump's appointment follows his ...

Telangana attracts ₹36,000 crore investments in life sciences, becoming a global leader in pharmaceutical manufacturing and R ...

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

Villagers have been fighting for justice for about nine months, yet neither the Chief Minister nor his officials had ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

Shares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, ...

Revenue: US$2.73m (down 33% from 3Q 2023). Net loss: US$162.0m (loss narrowed by 8.5% from 3Q 2023). US$0.86 loss per share ...

Glenmark Pharma continued to benefit from its strong position in key chronic therapy areas, including respiratory and dermatology therapeutics, according to its latest, opens new tab annual report.